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Abstract (word count 175) 
SA HealthPlus, one of nine national Australian coordinated care trials, aimed to inform policy 
to address the emerging crisis in chronic illness care. The trial tested the hypothesis that 
coordinated care would improve health outcomes within the costs of usual care. SA 
HealthPlus used geographic and randomised designs in eight projects in four sub-trials. A 
generic model of coordinated care was applied to 3115 intervention patients and compared to 
usual care in 1488 controls. Innovative aspects of the trial were the role of service 
coordinators and the behavioural and care planning approach used to place the patient at the 
centre of their care. Results showed improvements in self-assessed health status (SF-36) in six 
of eight projects and that patients with a history of prior hospitalisation in the year 
immediately preceding the trial were the most likely to yield cost savings. A mid trial review 
found that health benefits from coordinated care were more dependent on patient self- 
management than illness severity, a factor which subsequently led to the development of the 
Flinders self-management model in Australia. 
Key words: chronic disease, coordinated care, care plan, self-management, health outcomes 
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Introduction 
 
In Australia, coordination of care for patients with multiple service needs is 
vulnerable to mixed funding sources and lack of integration of systems of care. Both 
Commonwealth and State or Territory Governments fund public health services: the 
Commonwealth Government administers the taxpayer-funded Medicare program to provide 
universal access to public health services by funding General Practitioners (GPs) and 
specialists on a fee-for-service basis, whereas public hospitals are funded by State 
Governments. A mixture of State and Commonwealth programs fund community  care, 
including allied health services. Individuals can purchase private health insurance which 
provides private hospital care and a range of ancillary services (physiotherapy, psychology, 
podiatry etc). 
In 1997, Australian Governments began trials of coordinated care to develop and test 
models of service delivery for chronic conditions (Commonwealth Department of Human 
Services and Health, 1995). The impetus for reform has included escalating health care costs 
driven by an ageing population and advances in technology, a shift in emphasis of health care 
delivery from the tertiary to the primary care sector (World Health Organisation, 2002) and 
demands by consumers for more patient-centred care. 
The national primary hypothesis that trials were asked to test within a two-year time 
frame was: 
That coordination of care of people with multiple service needs, where care is accessed 
through individual care plans and funds pooled from existing Commonwealth, State and joint 
programs will result in improved individual client health and well being within existing 
resources. The principal intent of the trials was to ‘develop and test different service delivery 
and funding arrangements, and to determine the extent to which the coordinated care model 
contributes to: 
• improved client outcomes 
 
• better delivery of services which are individually and collectively more responsive to 
clients’ assessed needs 
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• more efficient ways of funding and delivering services.’ (Commonwealth Department of 
Human Services and Health, 1995). 
This paper describes SA HealthPlus, which comprised eight projects within four 
regional sub-trials across South Australia and was the largest of nine national coordinated 
care trials. Previous publications have provided a brief summary of the outcomes of trial 
(Battersby, 2005), and trial elements (Hurley et al., 2000; Harvey, 2001; Heard et al., 2002; 
Smith et al., 2002). The aim of this paper is to highlight the innovative aspects of the generic 
(not disease specific) model of care including the case management role, strengths and 
weaknesses of the model, implementation issues, and policy implications. 
Aim of the SA HealthPlus trial 
 
SA HealthPlus provided the opportunity to create and test the impact of a 
fundamental shift in the way health services are delivered from a funding based model to an 
outcomes based model. The funding based model is characterised by fee for service which 
provides incentives for throughput and reactive care rather than proactive care for chronic 
conditions, and by a system which is provider focused, fragmented, and where secondary and 
tertiary services are disease orientated. In an outcomes based model, the pool of funds 
provided by both State and Commonwealth governments for all aspects of care for a defined 
group of patients is used to achieve population health outcomes. The funding for a range of 
primary and acute care services is pooled to provide patient-centred, planned, evidence based 
coordinated care to achieve individual and population targets. 
An outcomes based system requires an information system to facilitate a continuous 
learning approach for both managers and clinicians. The major challenge for SA HealthPlus 
was to create and implement an outcomes based system within a two-year time frame, in 
order to realise  sufficient savings to cover  the  costs of  coordinating care, provide  the 
necessary preventive services, and fund the required systems changes as well as educate 
clinicians and administrators to adopt and use such an approach for the care of patients. 
Almost none of the six elements of the chronic care model (Wagner et al., 2001) were in place 
at beginning of the trial. 
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In effect, two concurrent research trials were conducted, the first directed at the 
individual level to improve health outcomes, and the second at the systems level in order to 
effect organisational change (Harvey, 2001). The trial was intended to provide new service 
delivery and funding systems for the South Australian population with chronic illness (Blight, 
1995). The sub-trials had broad geographical and clinical attributes. Three sub-trials were 
conducted in Southern, Central and Western metropolitan areas of Adelaide, the capital of 
South Australia, and one in the rural Eyre Peninsula region. The four sub-trials contained 
eight projects: Southern [Somatisation, aged care, chronic obstructive pulmonary disease 
(COPD)], Central [cardiac], Western: [type II diabetes, COPD] and Eyre: [chronic and 
complex, and type II diabetes]. 
The coordinated care intervention 
 
The trial addressed the hypothesis in two parts i.e. whether improved patient 
outcomes could be achieved and whether this could be done within existing resources. The 
model of care aimed to reduce the complications of illness by prospective, preventative care 
planning and to reduce or delay disability and handicap by assisting patients to achieve their 
goals. These two elements were designed to lead to ‘improved health and well being’. 
Achieving this within existing resources depended on preventing unplanned hospital 
admissions, and using the funds saved to pay for coordination and preventive services. 
The SA HealthPlus model addressed different coordination issues in separate but 
linked sets of strategies. Strategies to bring all of the medical costs for a group of patients 
under one fund and re-allocating them (funds pooling) addressed under-supply of necessary 
primary services and acute demand on tertiary services. Strategies around the structured care 
plan addressed reactive crisis care for chronic illness and the lack of communication between 
providers. Strategies relating to patient-centred care addressed the previous provider focus 
and fragmentation of services. 
1. Funds pooling 
 
Funds were contributed to the funds pool by public hospitals (inpatient services), the 
Medical   Benefits   Schedule   (MBS;   doctor   visits,   investigations   and   procedures), 
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Pharmaceutical Benefits Schedule (PBS; subsidized approved medications), Department of 
Veterans Affairs, and regional domiciliary services (home care for older people provided by 
community nurses and allied health organisations). 
2. The care plan 
 
The care plan was designed to be a global summary of the patient’s planned care over 
twelve-months, a motivational tool, a measure of outcomes over time, and a communication 
tool. It provided a record of demographic details, including details about the patient’s partner 
or community care giver, health service providers, diagnoses, investigation results, 
medications, services planned and services received. To break down barriers to coordination, 
all providers needed to use a common care plan, which contained a twelve-month overview of 
the planned care, including patient-defined problems and goals. The care plan complemented 
the detailed management plan of each provider. The process of creating the care plan was 
designed to engage the patient in their own care and begin the process of behavioural change 
to improve self-management of their chronic condition. 
2.1 Care Planning: Patient defined Problems and Goals (P&G) 
 
Use of the patient’s perception of their main life problem signified a fundamental 
shift in individual health management from a disease focus to a patient and problem focus. 
The Problems and Goals (P&G) approach was based on a semi-structured interview 
developed in the mental health field (Marks et al., 1977; Marks, 1986; Richards and 
McDonald, 1990; Fox and Conroy, 2000), based on motivation and behavioural change being 
enhanced by defining the patient’s (life) problem first, then their goals, rather than the more 
commonly used provider-generated list of goals. The patient’s perception of the impact of 
their chronic condition(s) was at the forefront of care planning (Battersby et al., 2001). 
Problem severity and goal achievement were rated on a 0-8 scale (8 = severe problem, 8= no 
progress towards the goal) by both patient and health care provider, so that care planning 
could be patient-centred, holistic, outcomes-based and motivational (Battersby, Ask et al., 
2001). The P&G assessment was completed as part of the initial assessment after enrollment 
of patients in the intervention group, as the first step in assisting the patient towards improved 
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self-management. The GP and other health workers could use the patient’s goals to encourage 
adherence to medical management. 
2.2 Care planning: Evidence based guidelines 
 
Clinical guidelines for each project were developed by multidisciplinary groups, 
which defined a set of criteria and associated preventative services for each of three levels of 
severity for the relevant disease or condition. The groups agreed on the minimum frequency 
of these services over a twelve-month period. The focus was on prevention of medical 
complications and hospital admissions. 
Hospital admissions, which were potentially preventable, were identified from 
hospital discharge data, resulting in a list of preventable Diagnostic Related Groups (DRGs) 
for each principal disease. To satisfy the financial component of the hypothesis, each project 
was set a target of reducing preventable admissions by 50% compared to the control group. 
In this way, the two components of the primary hypothesis were brought together i.e., a 
mechanism was created to achieve improved outcomes within existing resources, if hospital 
savings could be used to buy more effective coordination and preventive primary care 
services. Together with the GP’s medical assessment and the previous twelve months service 
history, the patient’s P&G statement contributed to the development of a structured twelve- 
month care plan by GPs, service coordinators (see below) and patients. GPs were paid a fee to 
develop each care plan as well as an annual fee to oversee their patients’ care and were 
supported by service coordinators who were employed in all trial sites. SA HealthPlus staff 
monitored patient outcomes in terms of service use, P&G (0-8) ratings, and health status 
measures throughout the trial, and provided this information to each patient’s GP. This 
process supported the commitment to continuous improvement that was a cornerstone of the 
SA HealthPlus strategy. 
3. Coordination and the continuous learning framework 
 
The roles of service coordinator (SG), GP and project leader were clearly defined. At 
the inception of the trial very few nurses or allied health professionals worked in Australian 
general practice where the GPs provided all patient services. GPs referred patients to other 
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providers in an inconsistent and uncoordinated way. The SC conducted the enrollment, 
administered trial questionnaires, conducted the P&G assessment and prepared a draft care 
plan based on the care plan generator and current or planned services provided by other health 
professionals involved in the patient’s treatment. The care plan generator provided a guide on 
the minimum recommended services for the main condition over a twelve- month period. The 
SC arranged an appointment for the patient with the GP who conducted a medical assessment. 
Based on this and his/her knowledge of the patient, and the patient’s P &G statements, the GP 
and patient agreed on the services in addition to those recommended by the care plan 
generator, to be added to the care plan over the following 12 months. Both GP and patient 
signed the care plan and a copy was made for the patient, the service coordinator, other 
providers and the original retained by the GP. 
The SC assisted the patient to arrange access to and coordinate the community and 
patient education services. Over the following months, the SC, through a combination of face 
to face and telephone contacts, worked with the patient to achieve their goal and self- 
management of their chronic conditions. The SC did not provide disease specific education. 
This was part of the planned services on the care plan. The SC provided a minimum 3 
monthly verbal or written report on the patient’s progress to the GP and had contact with the 
patient on average, monthly during the trial. Patients received a review of all aspects of the 
care plan by the SC and GP at 12 months and a new care plan was prepared for the following 
12 months. 
The GP oversaw the creation, implementation and monitoring of the care plan and 
provided both prospective and as-needed medical management. Project leaders, mostly 
specialists, supported GPs and service coordinators by reviewing care plans and conducting 
case conferences with complex cases. A model of continuous learning was provided by the 
project leaders’ committee which oversaw an annual review of the care plan guidelines using 
information provided by project aggregated data and case conferences (Frith et al., 2001). An 
electronic care plan which included individual patient service data was piloted with GPs and 
specialists towards the end of the trial (Warren et al., 2001). 
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4. Training and supervision 
 
The Coordinated Care Training Unit (CCTU) was established with mental health 
nurses who had strong backgrounds in behavioural psychotherapy. Service coordinators, who 
were mainly registered nurses, but also included allied health professionals such as 
physiotherapists and social  workers, initially received two days of training in the trial 
methodology, care planning and the P&G approach, followed by a competency assessment 
and accreditation that was reviewed annually. The CCTU supported service coordinators 
through individual and group supervision. 
Evaluation methods 
 
The trial evaluation was conducted by an independent Local Evaluation Team (LET) 
in accordance with the national evaluation framework (Commonwealth of Australia, 2001). 
As well as addressing the primary outcome measures of health status and resource use, the 
evaluation acknowledged that the trial involved changes in relationships, responsibilities, 
planning and financing for many people and organisations. The evaluation combined 
extensive quantitative analysis with qualitative approaches including interviews and focus 
groups with patients, service coordinators and GPs, document analysis and case studies. 
Trial design 
 
Participating patients meeting the admission criteria were allocated randomly to 
intervention or control groups (in the ratio of 2:1) after enrollment in the Southern and Central 
sub-trials. It was not possible to blind GPs and service coordinators to patient allocation, as 
the interventions of care planning and care coordination, which they provided, were available 
only to intervention patients. Some GPs were responsible for the care of control group 
patients as well as those in the intervention group. Geographically isolated control groups 
were recruited in the northern metropolitan area for the Western sub-trial, and in the rural 
Yorke Peninsula for the similarly situated rural Eyre Peninsula sub-trial. Service use was 
tracked for all enrolled patients, who were also asked to complete two survey instruments (see 
below). 
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Eligibility 
 
Eligibility criteria were defined by each project group within the broad framework of 
chronic and complex medical conditions requiring high service demand. For most projects, 
criteria included all of; a hospital admission in the twelve months prior to enrollment, 
frequent use of GP (>8 visits per year) and greater than four emergency or ‘outpatient’ 
(ambulatory) hospital visits. As recruitment progressed the criterion of requiring prior 
hospitalisation was relaxed to achieve recruitment targets and to accommodate some GPs who 
believed that their complex patients without prior hospitalisation would benefit from the 
intervention. Patients were excluded if they were medically or mentally impaired so as not to 
be able to give informed consent, complete survey forms or carry out trial related activities. 
The recruitment process took place between August and December 1997. Patients 
from GP lists were recruited by letter and phone contact. The SC visited the patient at home 
to enrol and randomise the patient, and conduct the P&G assessment on patients in the 
intervention group. 
Sample size 
 
Cost modelling from historical data of representative samples matching the eligibility 
criteria for each project prior to recruitment indicated that preventable admissions accounted 
for 36% of the cost of all hospital admissions. SA HealthPlus aimed to reduce preventable 
admissions by 50% with a resultant reduction in overall admissions of 18%. EPi Info 6 
Statcalc (Centers for Disease Control and Prevention, 1997) was used to determine sample 
size, based on the expected admission rate in the control group during the trial. For example, 
using a ratio of intervention to control of 2:1 (95% confidence limit, 80% power) and a 90% 
admission rate in the controls, the intervention sample size required to detect a 15% reduction 
in intervention admissions was 207. If the admission rate in the controls was 60% the 
intervention sample size required to detect a 15% reduction in admissions was 751. 
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Outcome measures 
Health and wellbeing 
Two instruments were administered to intervention and control group patients in all 
sub-trials (mainly by mail) at enrollment, at twelve months, and at the end of the trial, a 
period 19-27 months after enrollment. 
Self assessed health status (the SF-36) (Ware and Sherbourne, 1992) was used as a 
generic measure of self reported health and well being and had been validated in an 
Australian population (McCallum, 1995; Sanson-Fisher and Perkins, 1998). The Work and 
Social Adjustment Scale (WSAS) (Marks, 1985; Mundt et al., 2002) was used as a measure of 
disability and handicap for all intervention and control groups. The scale asks the client’s 
perception of the impact of their main problem on five areas of daily life; work; home 
management; social leisure; private leisure; and family and relationships. Each  area is 
measured on a 0-8 scale. While quick and easy to use and sensitive to change over time, it had 
not been validated in a chronically medically ill population. 
Other specific measures not reported here were used for intervention and control 
group patients in four projects. The P&G assessment, an essential component of the 
intervention and therefore used only with intervention patients, was also a key measure of 
patient and service coordinator perception of goal achievement over time. 
Service use 
 
Enrolled patients consented to tracking of their service use for the two years prior to 
enrollment, and for the duration of the trial. Service use data were available (in the absence of 
unique patient identifiers) for the major areas of service use: medical visits/services, 
medications, hospital admissions (public and private), metropolitan domiciliary services 
(allied health daily living support home care) and metropolitan home nursing care. Non- 
inpatient hospital data (e.g., outpatient, allied health, accident and emergency) was largely 
unavailable due to multiple incompatible information systems, complicated by the large 
number of hospitals involved. Data on private allied health and community services were not 
available. 
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Results 
Recruitment 
In 1997 and 1998 trial staff recruited 4603 patients and 295 GPs in the four regional 
sub-trials (Table 1). Between 1 and 90 patients per GP were recruited. The analysis presented 
here is based on the regional sub-trials as GPs and service coordinators provided the 
intervention to more than one project in the region. The Central [intervention/control (I/C) 
271/138] and Southern [(I/C) 887/427] sub-trials were randomised by patient and Eyre [(I/C) 
1353/513] and Western sub-trials [(I/C) 604/410] used geographic controls. 
One hundred service coordinators were trained during the trial, most of who worked 
in a team based at a single site in each region, with a small number being based in GP 
practices. Service coordinators had a case load of approximately 100 patients per full time 
equivalent position. 
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Table 1:  Demographic and health status data for patients in intervention and control 
groups in each sub-trial 
Patient Profile Central Western Southern Eyre 
  
Int. 
 
Control 
 
Int. 
 
Control 
 
Int. 
 
Control 
 
Int. 
 
Control 
Total Patients 271 138 604 410 887 427 1353 513 
Average age in 
years (at 
enrollment) 
 
74 
 
74 
 
67 
 
61 
 
73 
 
74 
 
62 
 
63 
% Males 49.4 51.4 48.2 46.2 42.1 42.9 48.6 48.3 
% Married/de facto 61.6 60.1 62.1 69.8 59.3 54.7 67.3 69.2 
% Healthcare card 
holder* 82.7 77.5 83.6 75.9 75.2 75.7 47.2 70.1 
% Veterans 12.2 8.0 7.9 5.8 20.4 21.3 7.2 9.9 
Average days in 
trial 540 571 529 592 568 615 622 621 
% withdrawing 
from trial 41 49 52 49 38 39 32 41 
Number (%) with 
Baseline SF-36 
data 
234 
(86.3) 
128 
(92.7) 
462 
(76.5) 
363 
(88.5) 
731 
(82.4) 
378 
(88.5) 
1033 
(76.3) 
488 
(95.1) 
Number (%) with 
follow up SF-36 
data 
99 
(36.5) 
57 
(41.3) 
215 
(35.6) 
164 
(40.0) 
417 
(47.0) 
211 
(49.4) 
653 
(48.3) 
351 
(48.9) 
Baseline SF-36 
(PCS)** 33.6 33.3 34.7 38.1 34.3 34.5 36.3 35 
Baseline SF-36 
(MCS)** 45.8 45.7 44.4 46.9 46.8 47.9 46.1 46.2 
*Individuals are eligible for a Healthcare card if they receive government social security 
payments eg, low income families, unemployment, disability and aged pension. Card 
holders receive government subsidies for medications and doctors’ visits. 
**Baseline SF-36 physical component summary (PCS) and mental component summary 
(MCS) scores are significantly below population norms (49.23 and 49.79 respectively) 
(Butterworth and Crosier, 2004). 
 
 
Exit from Trial 
 
Over half the patients enrolled (61% of intervention patients and 57% of control 
patients) remained in the trial until December 1999. Reasons for withdrawal included death 
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(5.1% of intervention group patients and 5.8% of control group patients), and dissatisfaction 
with the trial for a small proportion (2.1% of intervention and 1.3% of control patients.) Many 
of the 23.2% intervention patients who gave ‘other’ as the reason for withdrawal did not want 
the reason to be recorded as dissatisfaction (Centre for Health Care Evaluation, 2000). When 
re-consent was required in July 1999 due to the trial being extended beyond the original date, 
more control than intervention patients took the opportunity to withdraw. SF-36 data were 
available for 79% intervention patients and 91% control patients at baseline and for 44% and 
46% respectively at December 1999. 
Effects of the trial on patients 
 
The following case study (Centre for Health Care Evaluation, 2000) illustrates the 
impact of the Problems and Goals approach and care planning process in a man with COPD 
and complex health problems which had been worsening over the last five years: 
Problem statement: Shortness of breath, being on oxygen 16 hrs per day, and having to take 
medication at regular intervals means that going out is a “real hassle” therefore I have given 
up many of my activities. Rated 8 on how much the problem affected his daily activities: 8 = 
severe interference, 0= no interference. 
Goal statement: To recommence attending calligraphy activities/workshops for 1 day, once 
per month. [This would be very difficult for this patient due to his dependence on oxygen and 
his social circumstances.] Rated 8 on progress towards achieving this goal; 8 = no progress, 0 
= complete success. 
 
The patient found that the problems and goals approach allowed him to express his 
desire to return to a vocational interest and as a mechanism to reduce his dependency on 
oxygen to overnight use. His engagement in the process also meant that the goal was realistic 
and important, meaning he was fully committed to achieving the goal. The patient was also 
very involved in the care planning process which made him think about what was happening 
to his health and why. This led to recognition of his priorities and increased his motivation. 
This form of care planning also led to his general practitioner developing a better 
understanding of what was important in management to the patient and advising an alternative 
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way of using his nebuliser to enable him to stay longer off the oxygen. The SC was 
somebody else to talk to without feeling like he was “causing a problem”. The SC was also a 
significant resource for problem solving and in planning to go to appointments or visits 
beyond his home. 
As a result, the patient was able to reduce the impact of the problem from 8 to 4, and 
make complete progress toward achieving his goal (rated 0 at the end of the trial). These 
outcomes appear to have contributed to the patient’s overall wellbeing as measured by the SF- 
36; he recorded a positive improvement (+21 points) in his Mental Component Summary 
Score over time. 
Health and well being: SF-36 Results 
 
Patient attrition lowered completion rates at the end of trial for both intervention and 
control group patients to approximately half the patients who commenced the trial. As 
patients who withdrew completed no further instruments, ‘intention to treat’ analysis was not 
possible for the SF-36.  Little improvement was expected in self reported health status as 
measured by the SF-36, as the patients enrolled in these trials were likely to decline rather 
than  improve  (Eagar,  1997;  Centre  for  Health  Advancement  and  KPMG  Management 
Consulting, 1999). As reported previously, (Battersby, 2005) however, the intervention group 
in six projects showed significant improvements in at least one domain relative to the control 
group. Southern and Western Respiratory Projects showed improvements in mental health 
domains (mental health, vitality). Central Cardiac, Western Diabetes, Eyre Chronic and 
Complex and Southern Aged Care showed improvements in both physical and mental 
domains. The significant differences in SF-36 change scores reflected improved levels of well 
being in the intervention group over time, compared to the deterioration in the control group. 
Health and Well Being: The Work and Social Adjustment Scale 
Four items of this disability scale (0-8) and the total score (0-32) were used in the 
analysis (the ‘Work’ item was omitted as irrelevant to most patients in this study). The WSAS 
was administered by mail with the SF-36 for the control group, and by service coordinator for 
the intervention group because the score was used to monitor clinical progress. The patient 
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was blinded to previous scorings of the WSAS. Using baseline to end of trial mean difference 
scores, five of the eight projects showed significant improvements for WSAS for intervention 
group relative to control group over time (Table 2). 
Table 2: Work & Social Adjustment Scale, baseline to end of trial mean difference 
scores which were significantly different (p < 0.05) between intervention and control 
groups (higher score = improved health status) 
 
 
 
Eyre Chronic & 
Complex 
Social 
Private 
 
West Diabetes 
Family 
 
West COPD 
Total 
Private 
Family 
 
Southern COPD 
Home 
Social 
 
Southern Aged 
Care 
Home 
Social 
Private 
Intervention Control T Value 
Mean  Std Dev. Mean  Std Dev. T 
 
0.42 2.27 
 
-0.21 2.66 
 
3.13 
0.59 2.10 -0.10 2.44 3.72 
(N= 402) (N= 226)  
0.49 1.90 -0.13 2.25 2.34 
(N= 128) (N= 113)  
1.24 8.33 -1.19 7.00 1.94 
0.27 2.65 -0.47 2.18 * (F= 5.14) 
1.18 2.36 -0.31 1.91 4.35 
(N= 93) (N= 67 - 71)  
0.61 1.64 -0.57 2.50 2.74 
1.22 2.08 -0.54 2.87 3.95 
(N= 74) (N= 42 & 50)  
0.25 2.08 -0.17 2.37 1.93 
0.68 2.18 -0.43 2.50 4.96 
0.02 2.35 -0.23 2.35 5.51 
(N= 291) (N= 144 - 168) 
 
 
*For the western region an analysis of co-variance was conducted to control for the variable 
age (covariate) because the control group was significantly younger. The significant results 
of this analysis were reported for non-significant t-test results. 
Health and well being: Problems and Goals (P&G) 
 
The results indicated that up to 60% of patients (and their service coordinators) rated 
their main problem as improved between first and final scores (Battersby, 2005), with the 
somatisation project having the greatest proportion of patients with improved scores, and the 
cardiac project the lowest proportion. Between 40% and 60% of patients made some progress 
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towards achieving their first goal between the first and last set of ratings; a period ranging 
from 50 to 70 weeks in different projects. Up to one third of patients were further from 
achieving their goals at the end of the trial. There were significant (p < .05) positive 
correlations found between the P&G difference scores (from baseline to endpoint) with 
difference scores of the SF-36; (Spearman correlations r < 0.12) and WSAS (Spearman 
correlations r < 0.35). 
Care coordination 
 
SA HealthPlus implemented a consistent model of care coordination through the four 
sub-trials, combining trial processes (P&G assessment, care plan, monitoring of plan and 
goals) and staff (GP and service coordinator). Surveys and case studies suggested that the care 
coordination function was associated with improved patient confidence and well being when 
patients had a capacity to benefit and were engaged in the process, GPs were fully engaged in 
the process, GPs and service coordinators worked in partnership with patients, and the service 
coordinators’ style was culturally appropriate to both GP and patient. 
Effects of Care Planning 
 
Patients in the intervention group received services recommended by the evidence- 
based care plan developed by their GP, whereas patients in the control group received 
services based on the GP’s usual care. Analysis of the services received during the twelve 
month period of the care plan for intervention patients and controls over an equivalent time 
showed that intervention patients had significantly more lipid tests and bowel cancer 
screening tests than controls (Heard, Kalucy et al., 2002). Adherence to the care plan 
depended on voluntary involvement of GPs, patients and service providers as well as the 
timely availability of services. The service coordinator assisted adherence to the plan by all 
parties. 
Extent of benefit 
 
Service coordinators and GPs recognised that some trial patients had benefited little if 
at all. Some enrolled patients did not require the degree of coordination provided, and others 
needed service coordination for a comparatively short time, because their services were 
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already well coordinated, they were motivated, well supported and had stable health 
conditions. Service coordinators estimated that about 25% of their patients had made major 
improvements in wellbeing. They considered that the patients who had benefited most were 
living in difficult situations, were not previously linked into health and community services, 
lacked knowledge of their condition and available services, were depressed, lacked 
motivation to change behaviour, had lifestyle risk factors (eg diet, weight, smoking, alcohol) 
or had poorly controlled conditions characterised by hospital admissions. GP interviews 
confirmed these criteria. 
Self-management 
 
An un-anticipated consequence of the SA HealthPlus trial was the development of the 
Flinders Model of self management support (Regan-Smith et al., 2006). A mid-trial review of 
the model of care with service coordinators identified that the P&G approach was a successful 
method to implement patient-centred care and initiate behavioural change. However service 
coordinators were allocating coordination time according to their perception of patients’ self- 
management capacity rather than according to level of severity as intended in the model of 
care. For example, a patient with several co-morbid conditions, multiple medications, and 
high disability may have needed little service coordinator time because they were a good self- 
manager, had excellent family support and shared decisions with their GP. As a result, 
towards the end of the trial, the CCTU at Flinders University piloted an objective method, the 
Partners in Health scale and Cue & Response Interview (Battersby et al., 2003) to assess self- 
management capacity and incorporate this into the care planning process. The ‘Flinders 
Model’ of self-management support has since been provided as a training program to over 
2,000 clinicians across Australia. 
Effects of the trial on service use 
 
Hospital inpatient data were analysed according to total admissions, emergency 
admissions and elective admissions per time in trial using an ‘intention-to-treat’ basis, i.e., 
data from those patients who withdrew from the trial has been included (with permission) 
with trial completers. Combining all sub-trial data, hospital inpatient usage accounted for 
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52% of the cost of all services. Differences between intervention and control groups in 
admissions per trial day were analysed by Poisson regression, with adjustments made for 
historical service use (see below). 
The results indicated no significant change in inpatient hospital admissions in the 
randomised southern or central regions, while the two regions employing geographic controls 
showed effects but with contrasting results. In the Eyre trial there was a reduction in 
admission rates in the intervention group compared to the control group, mainly reflecting an 
increase in emergency admissions in the control group for the Chronic and Complex project. 
In the Western trial there was an increase in admission rates in the intervention group, mainly 
due to increase in elective admissions in both the Diabetes and Respiratory projects compared 
to the northern suburbs control groups. 
Overall, there was  no substantive change in Medical Benefits Schedule (MBS; 
medical  attendances  and  investigations)  or  Pharmaceutical  Benefits  Schedule  (PBS; 
subsidised approved medications) use between intervention and control group patients over 
the course of the trial, however in the somatisation project, there was a 45% reduction in PBS 
(drug) use in the intervention group compared to controls. For domiciliary (community allied 
health) services for which data were available, intervention patients made greater use of 
services than controls, due to improved access to services as a result of service coordination. 
Resource use 
Accurate estimation of the usual cost of care proved to be a difficult task, especially 
in projects with geographically isolated controls. Even though geographically isolated control 
group patients were matched according to project eligibility criteria, they differed in terms of 
historical use of services in the two years prior to the trial partly due to difference in service 
access and availability between the regions. Service use data were therefore adjusted for 
differences between intervention and control groups in the two years prior to the trial. Thus, if 
for example, hospital inpatient expenditure for the intervention group was 30 percent above 
that of the control group in the 2 years prior to the trial, the control group expenditure was 
adjusted  upwards  by  this  percentage  for  the  ‘live’  phase.  Table  3  shows  the  adjusted 
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difference in all service use categories between intervention and control groups for each sub- 
trial as cost per patient per day on trial. 
  
 
 
 
Table 3: Comparison of cost per patient per active day on trial between intervention and controls, adjusted for historical service use 
 
 Control Intervention 
 
Sub-trial 
No. 
active days 
on trial 
No. of 
services 
 
Expend. $ Cost per pt per active day 
No. 
active days 
on trial 
No. of 
services 
 
Expend. $ Cost per pt per active day 
Eyre  
281086 
 
15664.00 
 
558887 
 
1.99 
 
684402 
 
35360.00 
 
1156312 
 
1.69 MBS (medical services) 
PBS (medications) 281086 23727.00 555992 1.98 684402 56944.00 1338531 1.96 
Veterans 281086 2290.00 195360 0.70 684402 1799.00 118164 0.17 
Hospital inpatient 281086 897.27 1820614 6.48 684402 1960.83 4058552 5.93 
Hospital  non-inpatient 281086 63.00 3654 0.01 684402 37.00 2296 0.00 
Other 281086 10.00 370 0.00 684402 4174.00 147613 0.22 
Sub-Total 3134878 11.15 6821469 9.97 
South/Central1  
300380 
 
24901.00 
 
817462 
 
2.72 
 
546747 
 
47314.00 
 
1579116 
 
2.89 MBS (medical services) 
PBS (medications) 300380 26275.00 546107 1.82 546747 44959.00 957582 1.75 
Veterans 300380 2003.00 83427 0.28 546747 8171.00 428315 0.78 
Hospital inpatient 300380 690.48 1421987 4.73 546747 1396.22 2946586 5.39 
Hospital non-in patient 300380 273.00 16849 0.06 546747 850.00 53070 0.10 
Other 300380 5041.00 53872 0.18 546747 8918.00 155289 0.28 
Sub-Total 2939704 9.79 6119959 11.19 
Western  
214727 
 
16403.00 
 
555801 
 
2.59 
 
236359 
 
22676.00 
 
712236 
 
3.01 MBS (medical services) 
PBS (medications) 214727 17701.00 391363 1.82 236359 24177.00 564507 2.39 
Veterans 214727 330.00 33480 0.16 236359 2567.00 162325 0.69 
Hospital inpatient 214727 458.61 975658 4.54 236359 859.66 1874480 7.93 
Hospital  non-inpatient 214727 51.00 3498 0.02 236359 659.00 46562 0.20 
Other 214727 1017.00 16206 0.08 236359 4957.00 71156 0.30 
Sub-Total 1976005 9.20 3431266 14.52 
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Sub-trial 
Hospital inpatient 
int -control cost differences 
adjusted 
$ 
% 
Difference I/C 
Hospital inpatient 
(12 month patients) 
int-control  cost 
differences 
adjusted 
$ 
% 
difference 
(int -control) 
Costs of 
coord’n 1 
$ 
Costs of coord’n 1 
(12 month patients) 
$ 
1 Central was combined with Southern because of small sample size. ‘Hospital non-inpatient’ indicates emergency department and ambulatory attendances. 
‘Other’ indicates community allied health services and home nursing services. Both ‘hospital non in-patient’ and ‘other’ service data were complete only for 
the Southern sub-trial. 
From these analyses of service use data to the end of October 1999, combining all sub-trials and all costs, the intervention group showed a deficit of 
 
$4,842,898 – (adjusted) compared to the control group (usual care). Any savings in admissions to acute care were not sufficient to pay for coordination costs 
and additional community services. 
Table 4: Comparison of hospital savings/deficits (adjusted) between intervention and control groups with cost of coordination by region, and by 
selecting only those patients who had an admission in the 12 months prior to enrollment (12 month patients). 
 
 
 
 
 
 
 
Eyre 
 
+$447,990 
 
+9.6% 
 
+$965,283 
 
+24.2% 
 
$2,027,511 
 
$1,153,290 
South 2 -$479,920 -18.6% -$213,700 -10.1% $1,735,009 $958,272 
West +$270,243 +12.2% +$312,275 +17.3% $1,009,716 $455,712 
 
1 This includes costs of recruitment, care planning and coordination costs 
 
2 Includes central cardiac because of small sample size 
 
+ indicates a saving and – a deficit in costs for the intervention group compared to the control group. 
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Targeting  Enrollments 
 
In order to meet enrollment deadlines and quotas, the criterion of a hospital admission 
prior to enrollment was relaxed to include patients that clinicians considered were at risk of 
hospital admission. As a result, only 58% of enrolled patients had at least one hospital 
admission prior to enrollment (71% of Central Cardiac to 43% of Eyre Peninsula Diabetes) 
and 51.7% had a hospital admission during the live phase. This therefore reduced the potential 
hospitalisation base within the population cohort from which the savings could be generated. 
One of the effects of this change in entry criteria was that many enrolled patients had less 
need for coordination than anticipated. Costing data from analysis of those intervention and 
control patients having at least one admission in the 12 months prior to enrollment are 
presented in Table 4. 
Combining savings from hospital admissions for all sub-trials for the ‘12 month’ 
group results in changes in net savings in the hospital sector from $252,584 (2.7%) to 
$958,470 (12.2%), closer to the 18% on which cost neutrality modelling was based. Similarly 
the overall deficit reduces from $4.8 million to $1.7 million. This demonstrates the 
importance of appropriately targeting a particular patient group for coordinated care. The 
reduction in overall deficit is generated not only from increases in hospital savings but also 
from substantially reduced costs of coordination. 
Which SA HealthPlus patients were most likely to have hospital admissions? 
 
A major assumption of the trial was that coordinated care could reduce unplanned 
admissions to pay for substituted services. Predictors of unplanned admissions were 
determined by using data on admissions in the two years prior to coordination and during the 
intervention phase. Using an intention to treat approach (including those who withdrew 
during the trial), a Chi-squared Automatic Interaction Detector (CHAID) analysis (SPSS Inc, 
1997) was used for all 4603 patients enrolled in the trial. Predictor variables were gender, age 
group, marital status, language spoken at home, employment status, type of pension received, 
retirement status, health care card status, veteran status, need for a carer, ownership of private 
health insurance, number of co-morbidities, and number of hospital admissions during the 
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historical period. The greatest predictor of unplanned admissions was a history of three or 
more hospital admissions in the previous two years. This group accounted for 24% of the 
patient population, and had a 33% chance of one or more unplanned admissions per year. 
Within this group, the greatest probability of unplanned admissions was for those who also 
had four or more co-morbidities. 
Discussion 
 
In relation to the national trial hypothesis, the first element of ‘improved individual 
client health and well being’ was achieved as indicated by improvement in some domains of 
the SF-36 in six out of eight projects. SF-36 results are supported by WSAS data. It has not 
been possible to determine precisely which trial components were associated with 
improvements in wellbeing. The LET concluded that addressing fragmentation of care 
through patient-centred approaches of P&G monitoring, and service coordination in 
partnership with GPs was a more successful strategy for SA HealthPlus than the structured 
care plan or funds pooling strategies. 
There are no agreed definitions of the various models aimed at improving chronic 
illness care such as disease management, case management and coordinated care (Chen et al., 
2000). Weingarten et al (2002), using a broad definition of disease management, found in a 
meta-analysis that patient education, education of providers and feedback were the most 
commonly used interventions. SA HealthPlus adds to the evidence that incorporating a 
psychological and behavioural component rather than just a focus on disease is an important 
element of coordinated care. 
The P&G approach and associated motivational skills of the service coordinators 
enabled the patient to be at the centre of the GP-service coordinator interactions. This 
approach is supported by a review of successful coordinated care interventions by Chen et al 
(2000). However, the use of the patient’s life problem rather than a disease specific problem 
has not been used in previous trials. Using the patient’s problem engages the patient in their 
own care and identifies whether issues other than their health are a priority. The P&G 
approach works at an individual level, but the trial has also shown that aggregated scores can 
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measure progress of a group of patients over time and that the degree of goal change can be 
used to monitor the success of a program of care. The approach enables supporting and 
monitoring of practitioner competence in behavioural change techniques. 
The profound lesson that emerged from the trial was that coordination should be 
provided according to the patient’s self-management capacity not just disease severity i.e., 
self-management capacity may provide a method of determining who requires coordinated 
care. The Flinders Model of self-management support has become the basis of chronic disease 
self-management education for health professionals in the National Sharing Health Care 
demonstration projects (Australian Government Department of Health and Ageing, 2004). 
This care planning approach is generic and can be applied to a range of conditions and more 
than one condition in the same patient. It has been applied in Aboriginal populations with 
diabetes, mentally ill patients and to resident training in the United States (Lawn et al., 2006; 
Regan-Smith, Hirschmann et al., 2006). The Commonwealth, States and Territories have 
announced a $500 million strategy to address chronic illness in Australia in which education 
of clinicians in self-management support is a key component (Council of Australian 
Governments (COAG), 2006). 
Cost neutrality 
 
The savings to pay for coordinated care were not achieved. However the assumptions 
underpinning the evaluation did not reflect the reality of conducting such an ambitious trial. 
The costs attributed to ‘coordination’ are largely those of service coordination. Service 
coordinators had three overlapping roles of clinician, research officer and change agent. An 
accurate cost comparison with ‘usual care’ would require the time service coordinators spent 
in the development of the tools and processes, data collection, research tasks, trial 
administration, and change management to be disaggregated from their purely clinical role. 
What has emerged is the considerable cost of facilitating system change (Harvey, 2001). 
Further research into coordinated systems of care should try to disaggregate change 
management and research costs from provision of care costs. 
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Additionally, there was no explicit decision-making process to link the care planned 
services and anticipated savings from service substitution and reduced hospital admissions. 
The savings that were generated were automatically absorbed into the costs of providing 
coordinated care services to everyone in the trial, as well as the provision of allied health 
services. 
The failure to significantly reduce hospital admissions has  been described in a 
number of coordination programs and health service reforms. In the UK, Coulter (1995; 1996) 
found little evidence that developments in primary care were reducing the demand for 
secondary care. The general practice fund holding scheme led to investment by fund-holders 
in new practice-based services without reducing the demand for specialist care, rates of 
outpatient referral or hospital admission (Coulter, 1995; Coulter, 1996; Sisk et al., 1996). 
Improvements in primary care may increase demand because new needs are identified that 
would previously have gone unmet (Coulter, 1995; Coulter, 1996; Sisk, Gorman et al., 1996). 
In the USA (Sisk, Gorman et al., 1996) managed care for Medicaid beneficiaries resulted in 
greater satisfaction, yet, despite financial incentives to restrict services, there were no 
differences between intervention and control groups in overall use and costs of resources. 
Similarly, a review of disease management programs (Bodenheimer et al., 2005) noted the 
disease management companies’ problem of carving out populations who would deliver cost 
savings. There was little evidence of programs achieving both improved health outcomes and 
reduced costs. 
Additional reasons for the trial's inability to achieve cost neutrality were firstly that 
implementation of the care plan required adherence to the plan by GPs, patients and other 
service providers, as well as availability and accessibility of all necessary services. Secondly, 
it is doubtful that complications would have been reduced sufficiently in the time period of 
the trial to bring about the necessary changes in demand and therefore in hospital admissions. 
Thirdly, an unintended consequence was an increase in service use mediated by thorough 
assessment, needs identification through service coordinator home visits, increased patient 
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awareness of services, the planned preventive services and historical under-servicing in some 
areas. 
The fourth factor is patient selection. The trial has demonstrated the need to select 
patients who need improved coordination of health services, and are willing and able to 
engage with this model of care. The patients most suitable to achieve cost containment (eg, 
those with at least three hospital admissions in the previous two years) are not necessarily the 
same group who are most likely to benefit in terms of improved health and well being. A 
suggested model would be to limit service coordination to six months. The patient would 
remain in the care of their primary care team who would follow up on the changes made 
through the addition of coordination and self-management support. 
Strengths and Weaknesses of the model 
 
Strengths of this model of coordinated care were the generic components of 
assessment, the care plan generator and the care plan which were applied across many 
diseases with a range of medical and psychiatric co-morbidities, in different populations and 
regions. The model was feasible and acceptable to both providers and patients. The P&G 
component was integral to the model, providing a patient-centred approach that added a 
psychosocial dimension to care planning and assisted motivation and self-management. A 
core strength was the role of the service coordinator, providing assessment, coaching, 
communication and change management across all aspects of the trial. The ‘discovery’ of the 
importance of self-management capacity in determining eligibility for coordinated care and 
developing a method to assess and target self-management interventions to the individual was 
central to the continuous improvement aspect of the model. 
Weaknesses of the model included the indirect link between care planning, 
coordination and savings from reduced hospitalisation, and an inability to target coordination 
to those who would benefit. Once allocated to coordination there was no mechanism to cease 
provision of coordinated care, which meant that some intervention patients received 
unnecessary coordination throughout the trial. 
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Limitations 
 
Overall, the Australian coordinated care trials aimed to test the effectiveness of a new 
system of health service delivery within the constraints of a controlled trial and with a rigid 
hypothesis-driven national evaluation framework. The many evaluation challenges included 
variable selection and eligibility criteria that were relaxed during the recruitment period, 
variable disease severity, variations in the extent of coordination available in different areas, 
and widely different contexts for the four sub-trials. In some sub-trials, the same GP acted for 
both intervention and control patients. The ‘black box’ effect of the model of care made it 
difficult to attribute benefits of the intervention group to a particular component of the 
intervention package. 
The trial cohort included patients who were seriously ill as well as those who were 
not very ill, yet the same intervention processes were deployed for all patients. Secondly, 
there was no incentive for hospitals to participate in the coordinated care process as they 
continued to be funded on a throughput basis and any reduction in admissions for ‘in trial’ 
patients simply meant that more hospital places were available for ‘out of trial’ patients. It 
was not possible to ‘cash out’ hospital savings because this would have allowed the hospital 
funding base to be eroded. 
The variation in patient selection did enable analyses that demonstrated that in a short 
time frame of two years, the coordination process may have been cost effective for those who 
had a history of hospital admission and co-morbidity. In contrast, in 1-2 years, improved 
quality of life could be achieved with a wider range of patient severity and service use. It can 
be speculated that because care planned patients received more preventative services than 
control patients (Heard, Kalucy et al., 2002), potential gains in survival, quality of life and 
financial costs could be achieved over the longer term. 
The trial indicated that over time GPs became increasingly familiar with the care 
planning process, but the intervention was not in place for long enough for full 
implementation. GPs needed reminders to order services scheduled on the care plan. Patient 
adherence was affected by  access, distance, understanding, motivation, and cost. Other 
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service providers were hindered by lack of awareness of the care plan and budget constraints. 
Purchasing of services through SA HealthPlus was limited by the extent of services included 
in the funds pool. Communication difficulties between service providers were addressed to 
some extent through the SA HealthPlus information system. However, the completeness, 
timeliness and usefulness of the information were limited by lack of electronic links with 
GPs, and by low numbers of GPs with computers at the start of the trial. 
Policy Implications 
 
The coordinated care trials have been successful in beginning the systems and culture 
change necessary for a preventative chronic care model in Australia. Examples of subsequent 
system change include the introduction in 2005 of new chronic care MBS item numbers for 
GPs to fund GP Management Plans ($120) and Team Care Arrangement ($95) and a range of 
item numbers for the provision of allied health services to support the care planning process 
(Australian Government Department of Health and Ageing, 2005). The Commonwealth 
Government also introduced funding to employ practice nurses in rural and remote areas and 
a program to implement a national health information system (Australian Government 
Department of Health and Ageing, 2006). The National Sharing Health Care demonstration 
projects (Australian Government Department of Health and Ageing, 2004) have trialed 
models of self-management support (PricewaterhouseCoopers, 2005). These policy directions 
have been supported by all governments’ commitment to the National Chronic Disease 
Strategy and its four elements: a) prevention, b) early detection and intervention, c) 
integration and coordination, and d) self-management support (Council of Australian 
Governments (COAG), 2006). 
A key policy implication is that coordinated care is best provided by a team, not an 
individual physician. Where care is preventative and planned, most of the tasks can be carried 
out by nurses and allied health professionals with the physician carrying out medical tasks. 
This would free GPs to concentrate on more clinically demanding tasks and complex patients. 
The WHO has recommended nine system elements essential to redesigning care for chronic 
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illness (Epping-Jordan et al., 2001). In Australia, a change in business processes in general 
practice is therefore required to facilitate a shift from reactive to preventative care. 
Health reform has inherent personal, political and financial risks, often requiring 
‘hump’ funding to trial new models of care and bring about system and attitude change 
(Harvey, 2000). During the trial, a change of state government led to a loss of momentum for 
chronic illness health reform and dismantling of the trial management team. A new state 
government in South Australia instituted the Generational Health Review in 2003, which 
identified the same factors that led to the SA HealthPlus trial in 1997. The review identified a 
need to integrate care for chronic illness, enhance primary care networks and implement self- 
management programs (South Australian Department of Human Services, 2003). Second 
round national coordinated trials are now in their evaluation stage. 
Conclusions 
 
The SA HealthPlus trial of coordinated care demonstrated that improvements in 
individual health and well-being for some patients with chronic and complex conditions can 
be achieved through patient-centred care involving GPs working with a service coordinator, 
using the P&G approach and a structured evidence-based care plan. The two-year trial was 
not able to demonstrate sufficient reduction in hospital admissions to pay for the costs of 
coordinated care. A longitudinal study is required to better assess individual health changes 
and the effects of service substitution on costs and hospitalisation rates where multiple 
strategies at individual and system level are introduced in a short time frame. 
Service coordination was found to be a necessary additional role to that currently 
available in the health system. Being able to cross all health sector boundaries and incorporate 
behavioural change skills with a coordination role proved to be critical to the benefits of the 
trial. Better targeting of coordinated care, primarily those with prior hospitalisation and those 
who have potential to improve their self-management, are major lessons of the trial. These 
findings contribute to the emerging knowledge of core components of coordinated care for 
patients with chronic and complex health needs. 
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